0001193125-22-278410.txt : 20221107 0001193125-22-278410.hdr.sgml : 20221107 20221107060904 ACCESSION NUMBER: 0001193125-22-278410 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20221107 DATE AS OF CHANGE: 20221107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIORA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001580063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273950390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-258301 FILM NUMBER: 221363596 BUSINESS ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 855-293-2639 MAIL ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: PROGENITY, INC. DATE OF NAME CHANGE: 20150617 FORMER COMPANY: FORMER CONFORMED NAME: ASCENDANT MDX, INC. DATE OF NAME CHANGE: 20130625 424B3 1 d419261d424b3.htm 424B3 424B3

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-258301

Prospectus Supplement

(To Prospectus dated August 6, 2021)

 

LOGO

This prospectus supplement supplements and amends the prospectus dated August 6, 2021 (the “Prospectus”), as supplemented and amended by that certain prospectus supplement dated November 22, 2021 covering the offering, issuance and sale of up to a maximum aggregate offering price of $90,000,000 (the “Maximum Offering Price”) of our common stock that may be issued and sold under a sales agreement with B. Riley Securities, Inc., BTIG, LLC and H.C. Wainwright & Co., LLC (the “ATM Facility”).

Effective as of November 7, 2022, we have reduced the Maximum Offering Price to $70,000,000. As of the date of this prospectus supplement, 9,692,632 shares have been sold under the ATM Facility.

You should read this prospectus supplement, together with additional information described under the headings “Information Incorporated by Reference” and “Where You Can Find Additional Information” in the Prospectus carefully before you invest in our securities.

Investing in our securities involves a high degree of risk. Before making any investment in our securities, you should consider carefully the risks and uncertainties described in the section entitled “Risk Factors” beginning on page 2 of the Prospectus.

The date of this prospectus supplement is November 7, 2022.

GRAPHIC 2 g419261dsp1b.jpg GRAPHIC begin 644 g419261dsp1b.jpg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